Literature DB >> 2971643

Presence of insulinlike growth factor receptors and lack of insulin receptors on fetal bovine smooth muscle cells.

P D Lee1, R L Hintz, R G Rosenfeld, W E Benitz.   

Abstract

Previous investigations have demonstrated specific receptors and associated mitogenic actions for insulin and insulinlike growth factors I and II (IGF-I and II) in postnatal bovine aortic smooth muscle. Using fetal tissue we have observed different patterns of binding and action for these peptides. Smooth muscle cells isolated from near-term fetal bovine aortae were studied in early passage. Specific receptors for both IGF-I and IGF-II were identified. Specific binding averaged 5.7%/2.5 X 10(5) cells for IGF-I, and 16.2% for IGF-II, and 0.3% for insulin. High affinity Kd for both IGF receptors were nanomolar. IGF-II was fivefold less potent than IGF-I in displacing IGF-I binding. IGF-I showed no affinity for the IGF-II receptor. Insulin, at physiologic concentrations, was incapable of displacing either IGF-I or IGF-II binding. Cellular incorporation of [methyl-3H]thymidine was stimulated at the lowest dose of IGF-I tested, 0.5 ng/ml. IGF-II showed no effect up to 100 ng/ml, after which a sharp increase in incorporation was noted. Insulin had a similar effect only at concentrations greater than 0.5 micrograms/ml, with a maximal response noted at 5 to 10 micrograms/ml. Our results indicate that fetal bovine aortic smooth muscle cells have an abundance of IGF receptors but lack specific insulin receptors. In addition, IGF-II binding levels are three times higher than for IGF-I. These results are consistent with observations in other species, in which a predominance of IGF over insulin receptors has been demonstrated in fetal tissue, and provide further evidence for a role for the IGFs in embryonic cellular metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971643     DOI: 10.1007/bf02623903

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  33 in total

1.  Identification of receptors for insulin-like growth factor II in two insulin-like growth factor II producing cell lines.

Authors:  P D Lee; D Hodges; R L Hintz; J H Wyche; R G Rosenfeld
Journal:  Biochem Biophys Res Commun       Date:  1986-01-29       Impact factor: 3.575

2.  Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor.

Authors:  W E Benitz; D S Lessler; J D Coulson; M Bernfield
Journal:  J Cell Physiol       Date:  1986-04       Impact factor: 6.384

3.  Synthetic insulin-like growth factor II.

Authors:  C H Li; D Yamashiro; R G Hammonds; M Westphal
Journal:  Biochem Biophys Res Commun       Date:  1985-03-15       Impact factor: 3.575

4.  Inter-species comparison of somatomedin structure using immunological probes.

Authors:  D M Wilson; R L Hintz
Journal:  J Endocrinol       Date:  1982-10       Impact factor: 4.286

5.  Fetal rat myoblasts release both rat somatomedin-C (SM-C)/insulin-like growth factor I (IGF I) and multiplication-stimulating activity in vitro: partial characterization and biological activity of myoblast-derived SM-C/IGF I.

Authors:  D J Hill; C J Crace; S P Nissley; D Morrell; A T Holder; R D Milner
Journal:  Endocrinology       Date:  1985-11       Impact factor: 4.736

6.  Receptors for insulin-like growth factors and growth effects of multiplication-stimulating activity (rat insulin-like growth factor II) in rat embryo fibroblasts.

Authors:  S O Adams; S P Nissley; M Kasuga; T P Foley; M M Rechler
Journal:  Endocrinology       Date:  1983-03       Impact factor: 4.736

7.  Heterogeneity of insulin-like growth factor-I affinity for the insulin-like growth factor-II receptor: comparison of natural, synthetic and recombinant DNA-derived insulin-like growth factor-I.

Authors:  R G Rosenfeld; C A Conover; D Hodges; P D Lee; P Misra; R L Hintz; C H Li
Journal:  Biochem Biophys Res Commun       Date:  1987-02-27       Impact factor: 3.575

8.  Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues.

Authors:  C T Roberts; S R Lasky; W L Lowe; W T Seaman; D LeRoith
Journal:  Mol Endocrinol       Date:  1987-03

9.  Insulin and insulinlike growth factor receptors and responses in cultured human muscle cells.

Authors:  M Shimizu; C Webster; D O Morgan; H M Blau; R A Roth
Journal:  Am J Physiol       Date:  1986-11

10.  Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture.

Authors:  D Gospodarowicz; K Hirabayashi; L Giguère; J P Tauber
Journal:  J Cell Biol       Date:  1981-06       Impact factor: 10.539

View more
  5 in total

1.  Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities.

Authors:  K E Bornfeldt; R A Gidlöf; A Wasteson; M Lake; A Skottner; H J Arnqvist
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

2.  Insulin and insulin-like growth factor I differentially induce alpha1-adrenergic receptor subtype expression in rat vascular smooth muscle cells.

Authors:  Z W Hu; X Y Shi; B B Hoffman
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 3.  Unique aspects of the developing lung circulation: structural development and regulation of vasomotor tone.

Authors:  Yuangsheng Gao; David N Cornfield; Kurt R Stenmark; Bernard Thébaud; Steven H Abman; J Usha Raj
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

4.  Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells.

Authors:  S I Chisalita; H J Arnqvist
Journal:  Diabetologia       Date:  2005-08-11       Impact factor: 10.122

5.  Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II.

Authors:  S M Rosenthal; A Brunetti; E J Brown; P W Mamula; I D Goldfine
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.